FBRX Logo

Forte Biosciences, Inc. (FBRX) 

NASDAQ$5.52
Market Cap
$35.29M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
280 of 924
Rank in Industry
161 of 527

FBRX Insider Trading Activity

FBRX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$124,9981100
Sells
$000

Related Transactions

Riley Antony ACHIEF FINANCIAL OFFICER1$124,9980$0$124,998

About Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Insider Activity of Forte Biosciences, Inc.

Over the last 12 months, insiders at Forte Biosciences, Inc. have bought $124,998 and sold $0 worth of Forte Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Forte Biosciences, Inc. have bought $147,732 and sold $4.45M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Riley Antony A (CHIEF FINANCIAL OFFICER) — $124,998.

The last purchase of 22,514 shares for transaction amount of $124,998 was made by Riley Antony A (CHIEF FINANCIAL OFFICER) on 2024‑11‑21.

List of Insider Buy and Sell Transactions, Forte Biosciences, Inc.

2024-11-21PurchaseRiley Antony ACHIEF FINANCIAL OFFICER
22,514
0.5477%
$5.55$124,998+1.28%
2023-12-18PurchaseWagner Paul A.See Remarks
10,000
0.0286%
$0.75$7,525-16.54%
2023-12-14PurchaseWagner Paul A.See Remarks
10,000
0.0287%
$0.72$7,200-13.84%
2023-12-13PurchaseWagner Paul A.See Remarks
10,520
0.0284%
$0.70$7,351-14.63%
2023-12-12PurchaseWagner Paul A.See Remarks
4,776
0.013%
$0.65$3,088-8.74%
2023-12-11PurchaseWagner Paul A.See Remarks
25,000
0.0719%
$0.65$16,188-2.03%
2023-12-08PurchaseWagner Paul A.See Remarks
15,000
0.0406%
$0.62$9,300-2.52%
2023-12-07PurchaseWagner Paul A.See Remarks
36,203
0.0971%
$0.58$21,168+2.62%
2023-11-22PurchaseWagner Paul A.See Remarks
400
0.0011%
$0.43$172+35.40%
2023-11-20PurchaseWagner Paul A.See Remarks
6,966
0.0175%
$0.44$3,048+18.95%
2022-12-16PurchaseWagner Paul A.See Remarks
44,024
0.2759%
$1.07$47,000+2.04%
2022-12-15PurchaseWagner Paul A.See Remarks
55,976
0.3253%
$1.03$57,672-1.96%
2021-09-07SaleWagner Paul A.See Remarks
1M
7.2851%
$4.35$4.35M-65.57%
2021-09-07SaleRiley Antony AChief Financial Officer
25,000
0.1778%
$4.24$106,105-65.57%
2020-06-29PurchaseRiley Antony AChief Financial Officer
2,000
0.0544%
$14.11$28,220+145.46%
2020-06-26PurchaseRiley Antony AChief Financial Officer
4,700
0.1262%
$14.52$68,225+135.52%
2020-06-25PurchaseWagner Paul A.See Remarks
7,000
0.1998%
$14.48$101,356+150.76%
2020-04-14PurchaseOliveira Steven Michael10 percent owner
74,301
0.1242%
$1.19$88,418+54.56%
2020-03-02PurchaseOliveira Steven Michael10 percent owner
65,149
0.0283%
$1.35$87,756-0.52%
2019-05-30PurchaseHasnain Faheemdirector
43,000
0.0242%
$4.66$200,315-77.34%
Total: 28
*Gray background shows transactions not older than one year

Insider Historical Profitability

69.41%
Riley Antony ACHIEF FINANCIAL OFFICER
30776
0.4814%
$169,883.5231+140.49%
Oliveira Steven Michael10 percent owner
2873450
44.9446%
$15.86M20+27.02%
Wagner Paul A.See Remarks
1823236
28.5178%
$10.06M121+50.28%
Hasnain Faheemdirector
245857
3.8455%
$1.36M20
FOLETTA MARK GEVP & Chief Financial Officer
15042
0.2353%
$83,031.8420
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$14,315,062
61
-6.21%
$33.06M
$22,186,116
57
-43.73%
$37.31M
$53,490,060
55
19.35%
$30.29M
$23,895,365
34
-37.28%
$37.97M
$17,594,514
16
-20.37%
$33.77M

FBRX Institutional Investors: Active Positions

Increased Positions15+48.39%4M+497.97%
Decreased Positions12-38.71%129,955-17.64%
New Positions9New2MNew
Sold Out Positions8Sold Out91,368Sold Out
Total Postitions34+9.68%4M+480.33%

FBRX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fred Alger Management, Llc$6,577.0018.9%1.13M+1M+1,271.19%2024-12-31
Tybourne Capital Management (Hk) Ltd$3,596.0010.33%619,981+475,000+327.63%2024-12-31
Ikarian Capital, Llc$3,534.0010.15%609,225+609,225New2024-12-31
Orbimed Advisors Llc$3,480.0010%600,000+600,000New2024-12-31
Bvf Inc/Il$3,447.009.9%594,282+475,000+398.22%2024-12-31
Cable Car Capital, Lp$1,274.003.66%219,604+138,325+170.19%2024-12-31
Woodline Partners Lp$1,185.003.41%204,275+204,275New2024-12-31
Perceptive Advisors Llc$555.001.6%95,74200%2024-12-31
Boothbay Fund Management, Llc$517.001.49%89,191+89,191New2024-12-31
Farallon Capital Management Llc$203.000.58%35,000-37,413-51.67%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.